Current recommendations of the joint national high blood pressure committee

Area of Science:

• Cardiology
• Pharmacology

Background:

• Significant advancements in hypertension research have emerged since the 1988 Joint National Committee (JNC) report.
• The JNC V report introduces updated blood pressure categorizations and initial therapy recommendations.

Purpose of the Study:

• To summarize the key changes and recommendations presented in the JNC V report.
• To underscore the evolving therapeutic goals in hypertension management, including considerations for end-stage renal disease and the elderly.
• To define the expanded role of pharmacists in hypertension care.

Main Methods:

• Review and synthesis of the JNC V report guidelines.
• Analysis of new information regarding blood pressure categorization and pharmacotherapy.
• Identification of recommendations for patient management, particularly for elderly populations.

Main Results:

• The JNC V report modifies blood pressure categorization and suggests diuretics or beta blockers as preferred initial therapies.
• New data on the "J curve" phenomenon and end-stage renal disease present more complex therapeutic targets.
• The report includes novel recommendations for treating hypertension in elderly patients.

Conclusions:

• The JNC V report provides essential updates for managing hypertension, including specific guidance for the elderly.
• Pharmacists are pivotal in detecting, evaluating, referring, and ensuring compliance with antihypertensive therapies.
• Pharmacists can optimize treatment by suggesting alternatives to enhance efficacy, reduce dosing frequency, and lower costs.